CIK 0001020214 · Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680262011
- Phone
- 9252886000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 8-K Event Executive or director change · Shareholder vote results
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- SD Other Specialized Disclosure
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale Chief Legal Officer sold 49,024 shares at $1.45 ($71,085)
- 4 Planned sale Chief Operating Officer sold 75,989 shares at $1.45 ($110,184)
- 4 Planned sale President and CEO sold 193,913 shares at $1.45 ($281,174)
- 4 Planned sale Chief Financial Officer sold 59,887 shares at $1.45 ($86,836)
- 4 Planned sale Chief Medical Officer sold 49,024 shares at $1.45 ($71,085)
Page 5 of 76 · 1,513 filings